EZH2 and neoplasm: Indeed, treatment of the tumor cells with EZH2 specific inhibitor EPZ-6438 more significantly increased the levels of luminal markers ERα, GATA3, and CK18 in 3D cultures than in 2D culture (Supplementary Fig. 2d).